Clinical and neurophysiological characterization of muscular weakness in severe COVID-19
Covid-19
[키워드] Admission
affected
Biomarker
Care
characteristics of patient
clinical
clinical evaluation
clinically
Complication
COVID
COVID-19
Critical
Critical illness myopathy (CIM)
Critical illness polyneuropathy (CIP)
diagnosed
Diagnosis
discharged
disorders
Endotracheal intubation
evaluated
excluded
IL-6
intensive care
Intensive Care Unit-Acquired Weakness (ICU-AW)
intubation
material
Medical Research Council
MRC
muscular
Neuromuscular
neuromuscular disease
Neurophysiology
objective
Patient
patients
performed
protocol
Result
risk factor
severe COVID-19
Severe COVID-19 Infection
supplementary material
Ventilation
was performed
weakness
[DOI] 10.1007/s10072-021-05110-8 PMC 바로가기 [Article Type] Covid-19
[DOI] 10.1007/s10072-021-05110-8 PMC 바로가기 [Article Type] Covid-19